







This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To

New Alzheimer’s drugs clear brain plaque made of amyloid-beta. 9 years ago, researchers discovered another Alzheimer’s culprit called amyloid-ETA. Now, they’ve possibly figured out how it works. Learn how balancing these two suspects may hold the key to success in current clinical trials.

MEDICATION: Razadyne (generic galantamine) is an FDA-Approved daffodil extract for Alzheimer’s. Learn how it significantly lowered mortality & eased cognitive decline.

Is amyloid-beta plaque behind Alzheimer’s? A famous study proved “Yes”. Then news broke proving the study a fraud. Yet today’s best, newest Alzheimer’s drugs work by fighting plaque. Did fabricated scientific results accidentally set us on the path to a breakthrough?

Researchers are developing blood tests for Alzheimer’s that are less invasive and costly. A new one called Simoa may be the best answer yet.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On